Takeda Pharmaceutical Net Income 2010-2024 | TAK

Takeda Pharmaceutical annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Takeda Pharmaceutical net income for the quarter ending December 31, 2024 was $0M, a 100% decline year-over-year.
  • Takeda Pharmaceutical net income for the twelve months ending December 31, 2024 was $1.282B, a 9.3% decline year-over-year.
  • Takeda Pharmaceutical annual net income for 2024 was $0.994B, a 57.63% decline from 2023.
  • Takeda Pharmaceutical annual net income for 2023 was $2.346B, a 14.57% increase from 2022.
  • Takeda Pharmaceutical annual net income for 2022 was $2.048B, a 42.07% decline from 2021.
Takeda Pharmaceutical Annual Net Income
(Millions of US $)
2024 $994
2023 $2,346
2022 $2,048
2021 $3,534
2020 $407
2019 $982
2018 $1,682
2017 $1,069
2016 $665
2015 $-1,327
2014 $1,067
2013 $1,588
2012 $1,577
2011 $2,986
2010 $3,202
2009 $2,344
Takeda Pharmaceutical Quarterly Net Income
(Millions of US $)
2024-12-31
2024-06-30 $610
2024-03-31 $-46
2023-12-31 $719
2023-09-30 $-331
2023-06-30 $653
2023-03-31 $247
2022-12-31 $846
2022-09-30 $445
2022-06-30 $809
2022-03-31 $-703
2021-12-31 $508
2021-09-30 $418
2021-06-30 $1,823
2021-03-31 $1,843
2020-12-31 $887
2020-09-30 $38
2020-06-30 $767
2020-03-31 $391
2019-12-31 $-296
2019-09-30 $501
2019-06-30 $-188
2018-12-31 $336
2018-06-30 $720
2017-06-30 $1,303
2016-06-30 $926
2015-06-30 $202
2015-03-31 $-1,892
2014-12-31 $156
2014-09-30 $260
2014-06-30 $326
2014-03-31 $-43
2013-12-31 $457
2013-09-30 $360
2013-06-30 $296
2013-03-31 $462
2012-12-31 $236
2012-09-30 $409
2012-06-30 $1,119
2012-03-31 $-460
2011-12-31 $322
2011-09-30 $775
2011-03-31 $394
2010-03-31 $426
2009-09-30 $-1
2009-03-31 $705
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $45.692B $30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.840B 34.83
Zoetis (ZTS) United States $70.908B 26.46
Daiichi Sankyo, - (DSNKY) Japan $46.582B 23.70
Sandoz Group AG (SDZNY) Switzerland $20.090B 0.00
Merck (MKKGY) Germany $17.991B 14.89
Summit Therapeutics (SMMT) United States $17.794B 0.00
Shionogi (SGIOY) Japan $14.019B 0.00
United Therapeutics (UTHR) United States $13.596B 12.03
Neurocrine Biosciences (NBIX) United States $11.451B 39.22
IPSEN (IPSEY) France $9.860B 0.00
Orion OYJ (ORINY) Finland $8.661B 23.42
Corcept Therapeutics (CORT) United States $7.448B 60.54
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.542B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.134B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Grifols, S.A (GRFS) Spain $4.882B 0.00
Soleno Therapeutics (SLNO) United States $3.869B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.873B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.851B 9.99
Hypermarcas (HYPMY) Brazil $2.486B 16.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.297B 12.56
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.017B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.760B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.643B 0.00
Guardian Pharmacy Services (GRDN) United States $1.622B 0.00
Indivior (INDV) United States $1.528B 6.48
Evotec AG (EVO) Germany $1.527B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 168.00
Dyne Therapeutics (DYN) United States $1.297B 0.00
Ocular Therapeutix (OCUL) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 44.44
Collegium Pharmaceutical (COLL) United States $0.928B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Enliven Therapeutics (ELVN) United States $0.904B 0.00
Harrow (HROW) United States $0.895B 0.00
Ardelyx (ARDX) United States $0.866B 0.00
Xeris Biopharma Holdings (XERS) United States $0.783B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.732B 0.00
Akebia Therapeutics (AKBA) United States $0.670B 0.00
Xencor (XNCR) United States $0.593B 0.00
KalVista Pharmaceuticals (KALV) United States $0.592B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.94
Bioventus (BVS) United States $0.547B 13.92
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
CytoDyn (CYDY) United States $0.497B 0.00
Savara (SVRA) United States $0.494B 0.00
Elite Pharmaceuticals (ELTP) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.449B 0.00
Altimmune (ALT) United States $0.431B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.404B 8.45
Organogenesis (ORGO) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.07
Heron Therapeutics (HRTX) United States $0.322B 0.00
Aquestive Therapeutics (AQST) United States $0.277B 0.00
Nature's Sunshine Products (NATR) United States $0.253B 23.39
ProKidney (PROK) United States $0.211B 0.00
Wellgistics Health (WGRX) United States $0.195B 0.00
Liminatus Pharma (LIMN) $0.194B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Avita Medical (RCEL) United States $0.184B 0.00
OmniAb (OABI) United States $0.176B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.161B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Larimar Therapeutics (LRMR) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.14
Cassava Sciences (SAVA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 52.22
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Prelude Therapeutics (PRLD) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Surrozen (SRZN) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
DURECT (DRRX) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 8.31
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00